Positron Emission Tomography (PET) Scanners Market to Surpass USD 3.1 Billion by 2035, Driven by Digital Imaging, Hybrid Modalities and Personalized Medicine

The global positron emission tomography (PET) scanners market is entering a period of steady expansion as healthcare providers increasingly prioritize early diagnosis, personalized treatment, and advanced functional imaging. Valued at approximately US$ 2.2 billion in 2024, the global PET scanners industry is projected to expand at a CAGR of 3.2% from 2025 to 2035, surpassing US$ 3.1 billion by the end of 2035.

PET scanners are sophisticated diagnostic imaging systems that visualize metabolic and physiological activity in organs and tissues using radioactive tracers. Unlike conventional imaging technologies that primarily provide anatomical information, PET enables clinicians to observe functional changes, making it particularly valuable in oncology, cardiology, and neurology.

Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=79651

Market Overview: The PET scanners market is being supported by continued advances in diagnostic imaging, increasing healthcare infrastructure investments, and the growing clinical emphasis on early and accurate disease detection. PET technology has become particularly important in cancer diagnosis, tumor staging, treatment monitoring, and assessment of treatment response.

The technology is also expanding beyond conventional diagnostic applications. Pharmaceutical and biotechnology companies increasingly use PET imaging in clinical trials to evaluate drug response, while academic and research institutions employ PET for molecular imaging and disease research.

PET/CT scanners currently represent a significant modality within the market because they combine functional PET information with detailed anatomical CT images. PET/MRI systems are also gaining attention because they integrate metabolic and anatomical imaging while offering opportunities for applications requiring advanced soft-tissue characterization.

Key Drivers of Market Growth

The rising prevalence of chronic diseases remains a major factor supporting PET scanner adoption. Cancer, cardiovascular diseases, and neurological disorders frequently require accurate diagnosis, staging, monitoring, and follow-up, creating demand for imaging technologies capable of providing functional information.

According to the World Health Organization, noncommunicable diseases accounted for approximately 43 million deaths in 2021, representing about 75% of non-pandemic-related deaths globally. The increasing burden of chronic disease is consequently contributing to demand for sophisticated diagnostic infrastructure.

The growing adoption of personalized medicine is another important market driver. PET imaging can provide patient-specific information concerning metabolic activity and organ function, supporting treatment planning and disease monitoring. Its ability to characterize biological processes can help clinicians make more individualized clinical decisions.

Other growth factors include investments in hospitals and diagnostic imaging centers, favorable healthcare policies, expanding clinical research, increasing awareness of early diagnosis, and the integration of artificial intelligence with medical imaging.

Emerging Trends

Digital PET technology is emerging as an important trend in the industry. Compared with conventional analog systems, digital PET platforms can provide improved image quality and acquisition performance while supporting more efficient imaging workflows.

Artificial intelligence is another area attracting significant attention. AI-based image analysis can assist with image interpretation, workflow optimization, quantitative assessment, and data management. As imaging datasets become increasingly complex, software-driven solutions are expected to play a greater role in PET operations.

Hybrid imaging is also expanding. PET/CT remains widely used, while PET/MRI continues to attract interest for specialized applications. At the same time, manufacturers are developing more compact and potentially portable PET systems that could improve access to advanced imaging in outpatient facilities, regional centers, and community hospitals.

New Opportunities and Challenges

The market presents opportunities through technological innovation, development of advanced radiotracers, AI-enabled imaging software, and expansion into emerging healthcare markets. Partnerships between manufacturers, research organizations, pharmaceutical companies, and academic institutions can accelerate innovation in molecular imaging and radiotracer development.

However, the industry also faces challenges. High equipment and installation costs, specialized infrastructure requirements, regulatory considerations, radiotracer availability, and the need for trained professionals can affect PET adoption. Healthcare providers in developing markets may also face budget constraints when investing in advanced imaging systems.

Manufacturers are therefore exploring economical solutions, expanded production capabilities, distribution partnerships, and strategic acquisitions to address market-access challenges.

Buy this Premium Research Report to stay informed with key insights - https://www.transparencymarketresearch.com/checkout.php?rep_id=79651<ype=S

Regional Insight

North America held a leading position in the global PET scanners market in 2024, supported by established healthcare infrastructure, high healthcare expenditure, widespread adoption of advanced diagnostic technologies, and strong clinical research activity.

The region also benefits from the presence of major imaging technology companies and research institutions. Increasing utilization of PET in oncology, clinical trials, and hybrid imaging applications further supports market development.

Europe is supported by advanced healthcare systems and increasing adoption of sophisticated diagnostic technologies, while Asia Pacific represents an important expansion opportunity due to healthcare infrastructure development, rising diagnostic demand, and increasing investment in medical technology. Latin America and the Middle East & Africa are also expected to offer opportunities as healthcare facilities and diagnostic capabilities expand.

Competitive Landscape

The competitive environment is characterized by investments in digital PET, hybrid imaging, artificial intelligence, radiotracers, and software-enabled diagnostic solutions. Companies are also pursuing collaborations, acquisitions, distribution agreements, and geographic expansion to strengthen their market presence.

Key companies operating in the global PET scanners market include GE HealthCare, Siemens Healthcare Private Limited, CANON MEDICAL SYSTEMS CORPORATION, United Imaging Healthcare Co., Ltd., Koninklijke Philips N.V., Mediso Ltd, Kindsway Biotech, Neusoft Medical Systems Co., Ltd., Bruker, Shimadzu Corporation, MinFound Medical Systems Co., Ltd., Shenzhen Basda Medical Apparatus Co., Ltd., Positrigo AG, Positron, and SynchroPET.

Recent industry developments illustrate the pace of innovation. In June 2025, Shimadzu Corporation received U.S. FDA premarket notification for its PositView PET system for head and breast examinations. In June 2024, Siemens Healthineers announced the Biograph Trinion PET/CT system, focusing on imaging performance, efficiency, and applications across clinical settings.

Future Outlook

The outlook for the PET scanners industry remains focused on improving diagnostic accuracy, accessibility, workflow efficiency, and clinical utility. The combination of PET with CT and MRI, continued development of digital detectors, AI-based image analysis, compact systems, and advances in radiotracers is expected to influence the next phase of market development.

With healthcare systems placing greater emphasis on early detection and personalized treatment, PET is positioned to remain an important component of advanced diagnostic imaging. The global market is projected to grow from US$ 2.2 billion in 2024 to more than US$ 3.1 billion by 2035, representing a 3.2% CAGR during 2025–2035.

Frequently Asked Questions

How large was the global PET scanners market in 2024?

The global PET scanners market was valued at approximately US$ 2.2 billion in 2024.

What will be the size of the PET scanners market in 2035?

The market is projected to exceed US$ 3.1 billion by the end of 2035.

What is driving PET scanner market growth?

Key factors include the rising prevalence of chronic diseases, increasing demand for personalized medicine, healthcare infrastructure investments, growth of diagnostic imaging centers, clinical research, and integration of digital and AI technologies.

What is the expected CAGR of the market?

The global PET scanners market is projected to expand at a 3.2% CAGR from 2025 to 2035.

Which modality is prominent in the PET scanners market?

PET/CT is a prominent modality because it combines functional metabolic information from PET with anatomical information from CT, supporting disease localization, staging, and treatment monitoring.

Which region led the market in 2024?

North America held a leading position in the global PET scanners market in 2024, supported by advanced healthcare infrastructure, high adoption of diagnostic technologies, research activity, and healthcare investment.

Who are the prominent players in the PET scanners market?

Major participants include GE HealthCare, Siemens Healthcare Private Limited, CANON MEDICAL SYSTEMS CORPORATION, United Imaging Healthcare, Koninklijke Philips, Mediso, Kindsway Biotech, Neusoft Medical Systems, Bruker, Shimadzu, MinFound Medical Systems, Shenzhen Basda Medical Apparatus, Positrigo, Positron, and SynchroPET.

Explore Latest Research Reports by Transparency Market Research-

Asthma Spacers Market

Wearable Cardiac Monitoring Devices Market

Gynecological Devices Market

Portable Oxygen Concentrators Market

Pulmonary Drug Delivery Devices Market

Medical Sensors Market

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analyzed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Media Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Sales Inquiries: sales@transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com